Ledger.Open graph →
SEC Form D · filed March 23, 2023

Orchard Therapeutics plc

Offering
—
Sold
$34.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LONDON, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Steven M. Altschuler · LONDON, United KingdomDirectorJohn T. Curnutte · LONDON, United KingdomDirectorJames A. Geraghty · Cambridge, MADirectorJoanne T. Beck · LONDON, United KingdomDirectorBobby Gaspar · LONDON, United KingdomExec · DirectorMarc T. Dunoyer · LONDON, United KingdomDirectorFrank E. Thomas · LONDON, United KingdomExecAlicia A. Secor · LONDON, United KingdomDirectorCharles A. Rowland, Jr · LONDON, United KingdomDirectorJames A. Geraghty · LONDON, United KingdomDirectorJoanne T. Beck · LONDON, United KingdomDirectorBobby Gaspar · LONDON, United KingdomExec · DirectorMarc T. Dunoyer · LONDON, United KingdomDirectorSteven M. Altschuler · Philadelphia, PADirectorFrank E. Thomas · LONDON, United KingdomExecAlicia A. Secor · LONDON, United KingdomDirectorCharles A. Rowland, Jr · LONDON, United KingdomDirectorJohn T. Curnutte · LONDON, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗